A powerful Ayurvedic formula for the heart
- A combination of the most effective Ayurvedic herbs known to support the heart
- Promotes healthy heart function, blood flow, blood pressure & vascular health
- Reduces the heart-compromising effects of stress
$41.81 — or subscribe and save 20%
It is estimated that over 56 million Americans have some form of cardiovascular disease (CVD). Although CVD is increasingly common as people age, it is not an inevitable consequence of aging. Cardana Caps is an Ayurvedic herbal formula used to support the health of the heart and vascular system, promoting normal blood pressure and healthy blood flow to the heart muscle. It can promote a healthy heart rate, and reduces the effects of stress on the heart.
Cardana Caps contains five of the most powerful herbs used to support the cardiovascular system and a healthy blood pressure. Terminalia arjuna reduces blood pressure and heart rate, and increases the strength of the heart’s contractions. Coleus forskohlii is a powerful vasodilator that reduces blood pressure, and improves the efficiency of the heart’s contractions. Crataegus laevigata (also known as hawthorn), increases the force of cardiac contractions, improves blood flow, reduces the oxygen needs of the cardiac muscle, and is an anti-hypertensive and anti-arrhythmic agent. Boerhaavia diffusa is a diuretic, helping to reduce blood pressure. Withania somnifera, known as ashwagandha, supports cardiovascular health by reducing the effects of stress, which include a rapid pulse and increased blood pressure.
Those looking to support a healthy blood pressure and improve heart function will benefit from this Ayurvedic heart formula. Type A personalities who are prone to heart and blood pressure problems will particularly find Cardana Caps helpful.
Cardana Caps highlights several traditional Ayurvedic herbs and is in line with AOR’s philosophy of combining several ingredients with multiple mechanisms of action for an effective, well-rounded and safe approach.
Formulation of botanicals used in traditional Ayurvedic Medicine to help maintain and support cardiovascular health in adults.
AOR™ guarantees that all ingredients have been declared on the label. Contains no wheat, gluten, nuts, peanuts, sesame seeds, sulphites, mustard, soy, dairy, eggs, fish or shellfish.
Take one to two capsules twice daily between meals, or as directed by a qualified health care practitioner. Take a few hours before or after taking other medications or natural health products. Use for a minimum of two months to see beneficial effects.
Do not use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are taking cardiac glycosides such as digitalis/digoxin, blood pressure medication, diuretics or anticoagulants/blood thinners. Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended. Discontinue use if you experience mild gastritis, constipation, headaches and/or vomiting. Consult a health care practitioner if symptoms persist or worsen or if you experience new symptoms.
- Cardiovascular health
- Blood pressure balance
- Oxygen sparing
The information and product descriptions appearing on this website are for information purposes only, and are not intended to provide or replace medical advice to individuals from a qualified health care professional. Consult with your physician if you have any health concerns, and before initiating any new diet, exercise, supplement, or other lifestyle changes
Non-medicinal Ingredients: maltodextrin, microcrystalline cellulose, silicon dioxide, sodium stearyl fumarate and sodium benzoate. Capsule: hypromellose
In a double-blind, placebo-controlled crossover study, 58 males with chronic stable angina were given either 500 mg of Terminalia arjuna every eight hours, 40 mg isosorbide mononitrate daily, or placebo for one week each with a three-day washout period. Treadmill exercise was evaluated at the end of each therapy. Arjuna treatment was associated with significantly decreased angina frequency and the need for isosorbide dinitrate use. Arjuna treatment was also associated with significantly improved performance on the treadmill test: significant increase in total duration of exercise and significantly decreased time to recovery. These findings were similar in the isosorbide mononitrate group, but not with placebo.
Bharani A, Ganguli A, Mathur LK, et al. (2002). Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate. Indian Heart J. 54(2): 170-5
In a placebo-controlled trial, 116 patients with stable coronary artery disease were randomized to either 500 mg T. arjuna twice daily, or a placebo, in addition to their standard medications. After three months of treatment, arjuna therapy significantly down-regulated triglycerides, very-low-density lipoprotein (VLDL) cholesterol and other inflammatory markers compared to placebo.
Kapoor D, Trikha D, Vijayvergiya R, et al. (2015). Short-term adjuvant therapy with Terminalia arjuna attenuates ongoing inflammation and immune balance in patients with stable coronary artery disease: in vitro and in vivo evidence. J Cardiovasc Transl Res. 8(3): 173-86
In a randomized, placebo-controlled trial, 40 patients with ischemic mitral regurgitation after an acute myocardial infarction were given either 500mg of T. arjuna three times daily or placebo in addition to their anti-ischemic medication for three months. After the treatment period patients in the arjuna group had a significant decrease in mitral regurgitation and frequency of angina.
Cholesterol management effects
In a randomized, placebo-controlled trial, 105 patients with coronary heart disease (CHD) were given either 400IU vitamin E, 500mg T. arjuna bark powder or placebo daily for 30 days. The group given arjuna had significant reductions in total cholesterol (average of -9.7%) and LDL cholesterol (average -15.8%). Lipid peroxide levels were significantly lower in both the vitamin E and the arjuna groups after treatment. No changes in cholesterol levels or triglycerides were seen in the placebo group.
Gupta R, Singhal S, Goyle A and Sharma VN. (2001). Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: a randomized placebo-controlled trial. J Assoc Physicians India. 49: 231-5
In a double-blind, placebo-controlled study by Kapoor et al., 100 patients with coronary artery disease given 500mg arjuna twice daily in addition to conventional therapy had significant decreases in hyperlipidemia and in multiple inflammatory cytokines including IL-6 and TNF-alpha.
Additionally, in a study by Khalil of 30 patients with coronary artery disease, 500mg of arjuna combined with conventional therapy led to a 16% reduction in LDL, a 15% decrease in total cholesterol and 11% decrease in triglycerides.